Medical Device Manufacturing Partners You Can Trust — Verified, Certified & Compliant

The FDA classification of your device — Class I, II, or III — determines the regulatory burden and your manufacturer's involvement. Class I devices (e.g., bandages, tongue depressors) face minimal controls. Class II devices (e.g., blood glucose monitors, infusion pumps) require 510(k) premarket notification, which often involves biocompatibility, software validation, and shelf-life testing. Class III devices (e.g., pacemakers, hip replacements) require full premarket approval (PMA), which is a multi-year, heavily documented process. Your manufacturing partner must understand which class your device occupies and what that means for process validation, testing, and documentation. Quality System Regulation (21 CFR Part 820) is the FDA's baseline expectation for all device manufacturers. It covers design controls, document control, change management (design and production), production procedures, acceptance activities, complaint handling, corrective actions (CAPA), and management review. If your partner is not compliant with Part 820, you're exposed — the FDA can issue warning letters, consent decrees, or even seizures. When you evaluate shops on ManufacturingBase, filter for documented 21 CFR Part 820 compliance or active FDA establishment registration. International markets add layers. The CE Mark under the EU Medical Device Regulation (MDR 2017/745) requires a notified body review for higher-risk devices, post-market surveillance, and compliance with harmonized standards including ISO 13485. Japan's PMDA (Pharmaceuticals and Medical Devices Agency) has its own premarket pathway. Canada's MDCL, Australia's TGA — each market has expectations. If you're manufacturing for export, your partner needs clarity on which regions you're targeting so they can design processes and documentation to support multiple submissions.

Process validation is the FDA's requirement that you prove your manufacturing process produces a consistent, safe, effective device, lot after lot. For a sterile device, this means demonstrating that your sterilization method reliably kills pathogens to a specified sterility assurance level (SAL), usually 10^-6 (one organism in a million). Validation studies are expensive and time-consuming — they require running at least three consecutive production batches, collecting environmental monitoring data, and conducting sterility and other product testing. Your manufacturing partner must be equipped to support or conduct these studies. If your device is terminally sterilized (ETO gas, gamma radiation, or steam), your partner must either have in-house sterilization equipment or a validated contract sterilizer. Many medical device manufacturers partner with specialized contract sterilizers (e.g., Steris, Noxilizer, JLA in the U.S., or equivalents abroad). Your primary manufacturer handles the final assembly, packaging, and labeling, then ships to the sterilizer. The sterilizer validates the process, performs residual gas testing (for ETO), sterility release testing, and issues certificates. Your partner must coordinate this handoff seamlessly and maintain documentation linking every device to its sterilization lot. Cleanroom manufacturing is required for certain device categories. Implantable orthopedic devices, ophthalmic implants, and injectable drug delivery systems often demand ISO 14644 Class 7 or better (fewer than 3,500 particles ≥0.5 microns per cubic foot). This means controlled temperature, humidity, particle filtration (HEPA), garbing, and environmental monitoring. Not every shop has a certified cleanroom — if yours does, expect higher quotes and longer lead times to schedule production runs. On ManufacturingBase, cleanroom capability is a searchable filter; use it if your device requires Class 6, 7, or 8 conditions.